VanEck Associates’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
VanEck Associates's ALAB Position: Q2 2026 in Review
VanEck Associates increased its Astera Labs (ALAB) stake by 20% in Q2 2026, buying an estimated $99.1M and bringing the position to 2,237,961 shares worth $1.08B. The position accounts for 0.66% of the portfolio, ranked #28.
VanEck Associates first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- VanEck Associates held 2,237,961 shares of Astera Labs worth $1.08B as of Q2 2026.
- VanEck Associates bought 373,545 Astera Labs shares in Q2 2026, an estimated $99.1M.
- Astera Labs made up 0.66% of VanEck Associates's portfolio in Q2 2026, its #28 holding.
- VanEck Associates first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
- 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.